Monday, March 4, 2013

The Big Climb

March 24 is right around the corner. It's almost Big Climb time.  I think I've mentioned before that I did this event several years ago as one to do item on my 45 by 45 list.  At the time, it was simply a building climb for what seemed like a good organization, the Leukemia and Lymphoma Society (LLS) The LLS provides support and research funding for all blood cancers, including multiple myeloma.  So ironically, this event has a lot more meaning to me now.  Matt Arms and I have been training and doing a whole bunch of stair climbing.  Man, I'm getting to be a slow old geezer.

Nonetheless, if you want to contribute to a great organization. Here's your chance.

And as a little background......

What is the Big Climb?The Big Climb is a stairclimb up the Columbia Center - the tallest skyscraper in downtown Seattle.  There are 69 flights of stairs, 1311 steps, and 788 feet of vertical elevation.  Although it will be challenging, it pales in comparison to what blood cancer patients go through.  All proceeds benefit The Leukemia & Lymphoma Society. The video below captures the true spirit of the Big Climb.
Who is The Leukemia & Lymphoma Society?The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The mission of LLS is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
Every day, more than 347 LLS sponsored researchers come closer to the goal of finding a cure for leukemia and related blood cancers. Locally, LLS funds 7 researchers at the Fred Hutchinson Cancer Research Center and University of Washington Medical Center. Your support and commitment to the mission of LLS enables us to continue this important work of saving lives and aids us in our ability to reach patients in our community.

No comments:

Post a Comment

Berenson Oncology Success Rate

 Some reading about my myeloma specialist's success rate. A press release and an article from Targeted Oncology.